JPWO2023282269A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023282269A5 JPWO2023282269A5 JP2023533152A JP2023533152A JPWO2023282269A5 JP WO2023282269 A5 JPWO2023282269 A5 JP WO2023282269A5 JP 2023533152 A JP2023533152 A JP 2023533152A JP 2023533152 A JP2023533152 A JP 2023533152A JP WO2023282269 A5 JPWO2023282269 A5 JP WO2023282269A5
- Authority
- JP
- Japan
- Prior art keywords
- trisulfide
- pharma
- acceptable salt
- ceutically acceptable
- preventive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021113378 | 2021-07-08 | ||
| PCT/JP2022/026755 WO2023282269A1 (ja) | 2021-07-08 | 2022-07-05 | パーキンソン病の予防又は治療薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023282269A1 JPWO2023282269A1 (https=) | 2023-01-12 |
| JPWO2023282269A5 true JPWO2023282269A5 (https=) | 2024-04-04 |
Family
ID=84801700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533152A Pending JPWO2023282269A1 (https=) | 2021-07-08 | 2022-07-05 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240293359A1 (https=) |
| EP (1) | EP4342464A4 (https=) |
| JP (1) | JPWO2023282269A1 (https=) |
| CN (1) | CN117320709A (https=) |
| WO (1) | WO2023282269A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12552764B2 (en) | 2020-08-27 | 2026-02-17 | Kyowa Pharma Chemical Co., Ltd. | Trisulfide compound and clathrate thereof |
| TW202321270A (zh) * | 2021-09-09 | 2023-06-01 | 國立大學法人九州大學 | 使用三硫化合物之防止肝細胞增殖因子中之酪胺酸殘基之硝基化的方法 |
| WO2025070464A1 (ja) * | 2023-09-28 | 2025-04-03 | 協和ファーマケミカル株式会社 | トリスルフィド化合物を含有する医薬組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| WO2006043532A1 (ja) * | 2004-10-19 | 2006-04-27 | Ono Pharmaceutical Co., Ltd. | パーキンソン病治療剤 |
| WO2017177262A1 (en) * | 2016-04-11 | 2017-10-19 | University Of Canberra | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |
| EP3560947B1 (en) | 2016-12-20 | 2022-08-24 | Kyowa Hakko Bio Co., Ltd. | Crystal of glutathione trisulfide dihydrate and method for producing same |
| CN111699023A (zh) * | 2017-12-07 | 2020-09-22 | C·杜克 | 线粒体靶向、mptp调节以及线粒体反应物质和/或线粒体反应脂质物质的还原 |
| CN111320603A (zh) * | 2018-12-13 | 2020-06-23 | 江苏同禾药业有限公司 | 一种硫辛酸工艺杂质的制备方法 |
| JP2022074166A (ja) * | 2019-01-30 | 2022-05-18 | 協和発酵バイオ株式会社 | ポリスルフィド化合物を含有する組成物 |
| JP2022166333A (ja) * | 2019-09-18 | 2022-11-02 | 国立大学法人 熊本大学 | 活性イオウ分子種生体内濃度上昇剤 |
| CN115087635B (zh) | 2020-03-31 | 2024-04-12 | 协和医药化工股份有限公司 | 三硫化物化合物或硒代三硫化物化合物的制造方法 |
| JP7842033B2 (ja) * | 2020-05-12 | 2026-04-07 | ザ ジェネラル ホスピタル コーポレイション | 神経保護におけるグルタチオントリスルフィド（ｇｓｓｓｇ） |
| US12552764B2 (en) | 2020-08-27 | 2026-02-17 | Kyowa Pharma Chemical Co., Ltd. | Trisulfide compound and clathrate thereof |
| JP7650279B2 (ja) | 2020-08-27 | 2025-03-24 | 協和ファーマケミカル株式会社 | トリスルフィド化合物 |
-
2022
- 2022-07-05 EP EP22837683.6A patent/EP4342464A4/en active Pending
- 2022-07-05 CN CN202280032414.5A patent/CN117320709A/zh active Pending
- 2022-07-05 US US18/572,109 patent/US20240293359A1/en active Pending
- 2022-07-05 WO PCT/JP2022/026755 patent/WO2023282269A1/ja not_active Ceased
- 2022-07-05 JP JP2023533152A patent/JPWO2023282269A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023282269A5 (https=) | ||
| CN101384545B (zh) | 氘化的儿茶酚胺衍生物及包含所述化合物的药物 | |
| JP2018518537A5 (https=) | ||
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| JP2010523685A (ja) | リジン特異的デメチラーゼ阻害剤 | |
| RU2008127312A (ru) | Мезилатное пролекарство леводопы, его композиции и применение | |
| JP2004307506A5 (https=) | ||
| RU2015147509A (ru) | Новые композиции для предупреждения и/или лечения дегенеративных расстройств центральной нервной системы | |
| JP2009509922A (ja) | 抗寄生虫治療薬および抗癌治療薬ならびにリジン特異的デメチラーゼ阻害物質として有用なポリアミン類 | |
| JP2005523922A5 (https=) | ||
| JP2003517423A5 (https=) | ||
| JP2013500304A5 (https=) | ||
| JP2011527333A5 (https=) | ||
| JP2973271B2 (ja) | エンドペプチダーゼ２４．１５阻害剤 | |
| CY1112911T1 (el) | Θεραπευτικος παραγοντας ηπατικης νοσου, που περιεχει παραγωγο 2-αμινο-1,3-προπανοδιολης ως δραστικο συστατικο | |
| KR20110013411A (ko) | (ｆ-19)-표지된 ｌ-글루탐산 및 ｌ-글루타민 유도체 (ⅲ), 그의 용도 및 그의 수득 방법 | |
| CN103228618B (zh) | 新化合物及其医药用途 | |
| JP2007505044A5 (https=) | ||
| JP2021515011A (ja) | 小分子核内受容体モジュレータのアミドプロドラッグ | |
| JP2007518767A5 (https=) | ||
| JP2009040767A5 (https=) | ||
| BRPI0507334A (pt) | processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina | |
| FR2775901A1 (fr) | Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments | |
| EA018079B1 (ru) | Применение производных индола в качестве активаторов nurr-1 при лечении болезни паркинсона | |
| JP2010502585A5 (https=) |